Heteroaryl compounds for kinase inhibition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796712
SERIAL NO

15600023

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ARIAD PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bencivenga, Nicholas E Malden, US 9 17
Dalgarno, David C Brookline, US 55 602
Gong, Yongjin Belmont, US 6 21
Huang, Wei-Sheng Acton, US 58 567
Kohlmann, Anna Winchester, US 26 159
Li, Feng Winchester, US 810 5206
Shakespeare, William C Southborough, US 74 1018
Thomas, Ranny M Sharon, US 15 52
West, Angela V Franklin, US 14 23
Youngsaye, Willmen Boston, US 12 30
Zhang, Yun Acton, US 273 1506
Zhou, Tianjun Belmont, US 7 24
Zhu, Xiaotian Newton, US 73 1222

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00